Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 31 of 71 for:    TELMISARTAN AND HYDROCHLOROTHIAZIDE

Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00144222
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : November 5, 2013
Sponsor:
Information provided by:
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2005
Study Completion Date : August 2005